Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2017 | 10-year follow-up: the most effective treatment to ProtecT patients with localized prostate cancer?

An interesting update on the ProtecT trial (NCT02044172) was given by Freddie Hamdy, MBChB, LRCSPEd, LRCSEd, LRCPSGlasg, FRCSEd, MD, FRCSEd(Urol), FRCS, FMedSci, of the University of Oxford, Oxford, UK, at the 2017 National Cancer Research Institute (NCRI) Conference in Liverpool, UK. The ProtecT trial was a randomized Phase III trial that compared three interventions for patients with localized prostate cancer: radical prostatectomy, radiation therapy or active monitoring. Dr Hamdy discusses the study design and presents the findings from the 10-year median follow-up.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.